Imagine finally getting a knee replacement after dealing with years of crippling pain, only to develop a staph, or MRSA, infection at the surgery site. Not only is the pain still present, perhaps even worse, but rest of the body’s health is now at risk as well.Read More
Science Market Update
Researchers from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research have discovered a potential new method for treating brain cancer using specially engineered immune cells.
According to a university press release, personalized immune cells were engineered by UPenn scientists in order to seek out and attack a type of deadly brain cancer, and were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells.Read More
Researchers at Thomas Jefferson University may have found the ticket to helping men fight prostate cancer more efficiently and over a longer period of time. While prostate cancer is usually treatable in its early stages, men affected with cancer that has metastasized into their bones have a greatly reduced chance of fighting the deadly disease.Read More
Thomas Jefferson University is on the forefront of research lab science and healthcare development. Although the university is based in Philadelphia, Thomas Jefferson administrators and research lab scientists envision the school breaking out into the global science research market. Dr. Stephen K. Klasko, president of Thomas Jefferson University, has an innovative plan to unite Thomas Jefferson University, Thomas Jefferson University Hospitals and the institution’s 800 physicians under a single entity.
The University of Pennsylvania is currently in the planning stages of constructing a new research campus along the Schuylkill River. The South Bank of the Schuylkill, pronounced ‘SKOO-kəl,’ is a vital component of the University of Pennsylvania’s campus development vision. The Penn Connects 2.0 strategy has added 3 million square feet of space to new UPenn research campuses since 2006.
Researchers at the University of Pittsburgh recently received $10.4 million in life science funding from the NIH at the end of July this year. The administering center for the award at the NIH was the National Center for Advancing Translational Sciences, and the life science funding will be given to the University of Pittsburgh Clinical and Translational Science Institute. More information on the Clinical and Translational Science Institute is available on the NIH RePORTER project abstract:
Lab suppliers working to market life science solutions in Philadelphia will find a market rich with life science funding at Thomas Jefferson University. According to recent NIH and NSF funding statistics, the NIH awarded Thomas Jefferson University $49.7 million in research funding in 2012. In addition to receiving NIH research funding, Thomas Jefferson University received $318,984 in NSF life science funding for life science projects alone.
In an article on our Science Market Update blog last week, we featured some life science funding news stories that we covered in our Life Science Company and Industry News Briefs blog the week before. We’d like to do the same this week because a number of last week’s funding news stories may be of interest to lab suppliers working to sell lab equipment at these well-funded research institutions. In the following paragraphs, we’ll give a brief summary of what schools received funding, how much funding they received, and what the topic of research is. We’ll also include links for further reading.
Tags: 2014, Emory University, Harvard University, Pennsylvania, Northeast, University of Pennsylvania, UPenn, University of North Carolina at Chapel Hill, Duke University, North Carolina, University of North Carolina, Life Science Funding, Southern, Georgia, Massachusetts, Boston, Philadelphia, Emory, BioResearch Product Faire Event, Durham, Harvard, Atlanta, Front Line, Chapel Hill, Duke, UNC
The University of Pennsylvania recently celebrated the completion of one of its most successful fundraising projects in history when Penn Medicine Washington Square opened on Thursday. The new facility is 153,000 square feet and located in Center City Philadelphia. It was designed with environmentalism in mind, which is evidenced by the greenery growing on the building’s roof. The building will serve as an outpatient care facility for Pennsylvania Hospital.